Report Summary

Kendle International Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Kendle International (Kendle) is a global clinical research organization (CRO) that provides a broad range of Phase I-IV global clinical development services to the biopharmaceutical industry. The company provides clinical research services and proprietary information technology to biopharmaceutical companies to enhance their research and development activities. The company operates primarily in North America, Europe, Asia/Pacific, Latin America and Africa. It is headquartered in Cincinnati, Ohio and employs about 3,050 people. The company recorded revenues of $373 million during the fiscal year ended December 2006, an increase/a decrease of 49% over 2005. The operating profit of the company was $20 million during the fiscal year 2006, an increase of 16% over 2005. The net profit was $8.5 million in fiscal year 2004, a decrease of 20% over fiscal year 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available